As reported by Marijuana Moment, officials of the U.S. National Institutes of Health (NIH) replied to two senators’ request for a psychedelics research update with a letter stating that federal prohibition makes it harder to study the benefits of psychedelics.
“Because psychedelic drugs are controlled substances, one additional regulatory consideration for basic and applied research using psychedelic drugs is that these studies must also follow Drug Enforcement Administration (DEA) requirements, including registration, inspection, and certification of the drugs. These requirements apply to all psychedelic drugs, including natural or botanical products,” according to the document.
